Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Briacell Therapeutics Corp T.BCT

Alternate Symbol(s):  BCTX | BCTXW

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted... see more

TSX:BCT - Post Discussion

Briacell Therapeutics Corp > Going back up to $8?
View:
Post by opsd1 on Oct 02, 2024 2:22pm

Going back up to $8?

Yesterday's news was something rare and special.

Comment by loopsbutterfly on Oct 02, 2024 2:48pm
I do agree and that's why I bought back on the cheap lately some as low as $0.66 per share gracias    grinnnnn...
Comment by Iseneschal on Oct 02, 2024 3:37pm
How did QNTM work out for u?
Comment by loopsbutterfly on Oct 02, 2024 8:50pm
a nice swing trade today...out at $1,37 near the close gracias   grinnnnn..
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities